N1,N1,N6,N6-Tetrakis(2-hydroxyethyl)adipamide, 95.0%, 5g

3,6-Dibromothieno[3,2-b]thiophene, 95.0%, 1g

2-Bromo-4-methylbenzonitrile, 97.0%, 1g

4-benzoyl-8-tert-butyl-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

Ethyl 2-methyl-6,7-dihydro-5h-pyrrolizine-3-carboxylate, 98%, 1g

Benzoic acid, 4-(aminosulfonyl)-, ethyl ester, 95.0%, 2.5g

Flacon pour collyre Actiomedic® BioPhos®74 solution, 1 pièce

(2-HYDROXY-4-MORPHOLINOPHENYL)(4-METHOXYPHENYL)METHANONE, 95.0%, 250mg

Methyl 2-oxopiperidine-4-carboxylate, 95.0%, 250mg

4-(2-Hydroxyethyl)piperazin-2-one, 95.0%, 2.5g

2-(4-Methyl-2-pyridinyl)-4-pyridine propanol, 90.0%, 1g

1-(Tert-butoxycarbonyl)-5,5-dimethylpyrrolidine-2-carboxylic acid, 95.0%, 250mg

4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)morpholine, 95.0%, 5g